Deputy Director for Intramural Research at the National Institutes of Health, leading AI-driven drug discovery initiatives. Dr. Gottesman is a renowned researcher in drug resistance mechanisms in cancer cells, with a focus on the role of ABC transporters such as P-glycoprotein. His laboratory uses CRISPR screens and zebrafish models to study drug resistance and identify novel mechanisms that may lead to improved treatment strategies. With an impressive background in medicine and molecular genetics, Dr. Gottesman has made significant contributions to the field of drug discovery and resistance.